Print

‘Unbiased’ News Source? Reuters Chairman Is Top Investor and Board Member of Pfizer
By Emily Mangiaracina
Global Research, December 10, 2021
LifeSiteNews 7 December 2021
Url of this article:
https://www.globalresearch.ca/unbiased-news-source-reuters-chairman-top-investor-board-member-pfizer/5764305

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @crg_globalresearch.

***

 

The chairman and former Chief Executive Officer (CEO) of international news agency and “fact checker” Reuters is also a top investor and board member of Pfizer.

James C. Smith’s influential roles in both organizations “raises serious conflict of interest concerns,” the National Pulse remarked, because Reuters has not only given extensive coverage to Pfizer’s COVID-19 shot in particular, but it has overwhelmingly moved to “silence skeptics” of the Pfizer shots as well as other COVID-19 shots.

Smith’s roles raise added concern because Reuters, considered a leading international news source and boasting a reach of billions of people, brands itself as a news agency with “integrity” and “freedom from bias.” In fact, a 2021 article praises Reuters as one of the “Top 4 Unbiased Independent World News Sources.”

The National Pulse linked to a compilation of Reuters articles mentioning Pfizer, pointing to about 22,000 over “the last year alone.” Such articles portray Pfizer in an overal positive light, and at times Reuters aims to discredit Pfizer’s critics. The Pulse observed that articles mentioning Pfizer heavily outweigh those mentioning Moderna, which numbered about 8,200.

What gives Smith’s conflict of interest even greater weight is Reuters’ self-appointed role as “fact checker” of news. A survey of Reuters’ more recent fact checks shows the majority are dedicated to defending COVID-19 shots against questioning of their safety or efficacy, or of the motives behind their production and promotion.

For example, one recent “fact check” claims that “there is no evidence currently that COVID-19 vaccines are linked to an increase in sportspeople collapsing or dying due to heart issues such as myocarditis.” It made this claim despite its acknowledgement that “several studies do indeed suggest a link between myocarditis and the Pfizer/BioNTech and Moderna vaccines.”

Former Pfizer vice president Dr. Michael Yeadon has documented at least two dozen recent incidents of athletes collapsing, suffering injury, or dying, mostly from heart issues, noting that the rate of such occurrences has spiked in recent weeks.

However, more often than not, reports from people suffering injury after COVID-19 vaccination testify that doctors have either claimed their symptoms aren’t real or have dismissed out of hand the possibility of any link of those symptoms to COVID-19 jabs.

Other examples of such COVID jab-defending articles include “No evidence that Pfizer’s COVID-19 vaccine causes Alzheimer’s disease;” and “No evidence to support claim by ex-Pfizer scientist on COVID-19 vaccine safety in children,” referring to Dr. Yeadon’s declaration that “COVID-19 vaccines are ‘50 times more likely’ to kill children than COVID-19 itself.”

It is noteworthy that Smith also serves on the board of the World Economic Forum (WEF)’s Partnering Against Corruption Initiative and is a member of WEF’s International Business Advisory Boards of British American Business and the Atlantic Council.

Smith remains chairman of Reuters after having retired as president and CEO in February 2020, Pfizer’s website notes.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Twitter

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article.